Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Blood

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2007-07-096065PMID 18195096PMCID PMC2275033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.

  2007cited by this paper
• Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.

  2007cited by this paper
• Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.

  2007cited by this paper
• Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project

  2007cited by this paper
• Topoisomerase II and the etiology of chromosomal translocations.

  2006cited by this paper
• Biochemical mechanisms of chromosomal translocations resulting from DNA double-strand breaks.

  2006cited by this paper
• The MLL recombinome of acute leukemias

  2006influential reference
• Modeling oncogenic translocations: distinct roles for double-strand break repair pathways in translocation formation in mammalian cells.

  2006cited by this paper
• A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy.

  2006cited by this paper
• BglII‐based panhandle and reverse panhandle PCR approaches increase capability for cloning der(II) and der(other) genomic breakpoint junctions of MLL translocations

  2006cited by this paper
• Genomic DNA of leukemic patients: Target for clinical diagnosis of MLL rearrangements

  2006cited by this paper
• Fission yeast MO25 protein is localized at SPB and septum and is essential for cell morphogenesis

  2005cited by this paper
• FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression.

  2005cited by this paper
• AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner.

  2005cited by this paper
• The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.

  2005cited by this paper
• Effects of topoisomerase 2 inhibitors on the MLL gene in children receiving chemotherapy: a prospective study

  2005cited by this paper
• The life-threatening complications of dermatologic therapies.

  2005cited by this paper
• Clonal expansion of a new MLL rearrangement in the absence of leukemia.

  2005cited by this paper
• Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia.

  2005cited by this paper
• Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia.

  2004cited by this paper
• Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase Complex with Menin To Regulate Hox Gene Expression

  2004cited by this paper
• Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization

  2004cited by this paper
• Reciprocal DNA topoisomerase II cleavage events at 5′-TATTA-3′ sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing

  2003cited by this paper
• FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress.

  2003cited by this paper
• Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.

  2003cited by this paper
• Apoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division.

  2003cited by this paper
• Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment.

  2003cited by this paper
• Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: Almost identical MLL breakpoints in therapy‐related AML after treatment without etoposides

  2003cited by this paper
• Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique.

  2003cited by this paper
• Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression.

  2003cited by this paper
• A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases

  2003cited by this paper
• Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.

  2003influential reference
• The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21)

  2003cited by this paper
• MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice.

  2003cited by this paper
• FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy.

  2003cited by this paper
• MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

  2002cited by this paper
• Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties.

  2002cited by this paper
• ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.

  2002influential reference
• Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6

  2002cited by this paper
• Sensing and repairing DNA double-strand breaks.

  2002cited by this paper
• Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins

  2001influential reference
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Apoptotic triggers initiate translocations within the MLL gene involving the nonhomologous end joining repair system.

  2001cited by this paper
• Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints.

  2001cited by this paper
• Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia

  2001cited by this paper
• Nucleolytic Cleavage of the Mixed Lineage Leukemia Breakpoint Cluster Region during Apoptosis*

  2001cited by this paper
• The furry gene of Drosophila is important for maintaining the integrity of cellular extensions during morphogenesis.

  2001cited by this paper
• The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia

  2001cited by this paper
• Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation

  2001cited by this paper
• Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.

  2000cited by this paper
• Chromatin‐related properties of CBP fused to MLL generate a myelodysplastic‐like syndrome that evolves into myeloid leukemia

  2000cited by this paper
• t(3;11) translocation in treatment-related acute myeloid leukemia fuses MLL with the GMPS (GUANOSINE 5' MONOPHOSPHATE SYNTHETASE) gene.

  2000cited by this paper
• Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.

  2000cited by this paper
• The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q.

  2000cited by this paper
• Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation.

  2000cited by this paper
• Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed lineage leukemia protein in a therapy-related leukemia with t(3;11) (p21;q23).

  2000cited by this paper
• Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia.

  1999cited by this paper
• A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells

  1999cited by this paper
• ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23).

  1998cited by this paper
• DNA sequence selectivity of topoisomerases and topoisomerase poisons.

  1998cited by this paper
• Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints

  1998cited by this paper
• DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis

  1997cited by this paper
• MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).

  1997cited by this paper
• Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias.

  1997cited by this paper
• All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.

  1997cited by this paper
• Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX–ENL

  1997cited by this paper
• An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes.

  1996influential reference
• Complete exon structure of the ALL1 gene.

  1996cited by this paper
• Exon/intron structure of the human ALL‐1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias

  1996cited by this paper
• Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).

  1995cited by this paper
• ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.

  1995cited by this paper
• The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation.

  1994cited by this paper
• Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.

  1994cited by this paper
• ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements.

  1994cited by this paper
• Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.

  1993cited by this paper
• The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene.

  1992cited by this paper
• The (4;11)(q21;q23) chromosome translocations in acute leukemias involve the VDJ recombinase.

  1992cited by this paper
• Cytogenetic Studies in Acute Promyelocytic Leukemia: A Survey of Secondary Chromosomal Abnormalities

  1991cited by this paper
• Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.

  1991cited by this paper
• Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II.

  1990cited by this paper
• Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung.

  1987cited by this paper
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method

  year unknowncited by this paper
• t ( 11 ; 17 ) ( q 23 ; q 21 )

  year unknowncited by this paper

• KMT2A‐MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8‐year follow‐up

  2021cites this paper
• Studies on anti-leukemic terpenoids from medicinal mushrooms and marine sponges with ChemGPS-NP-based targets investigation of lead compounds

  2017cites this paper
• Recently Discovered Fusion Genes and Their Implications in Cancer

  2017cites this paper
• Genome-wide TOP2A DNA cleavage is biased toward translocated and highly transcribed loci

  2017cites this paper
• Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia

  2017cites this paper
• Antileukemic Scalarane Sesterterpenoids and Meroditerpenoid from Carteriospongia (Phyllospongia) sp., Induce Apoptosis via Dual Inhibitory Effects on Topoisomerase II and Hsp90

  2016cites this paper
• From initiation to eradication: the lifespan of an MLL-rearranged therapy-related paediatric AML

  2015cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2014cites this paper
• Phytochemicals as anticancer and chemopreventive topoisomerase II poisons

  2014cites this paper
• Topoisomerase II and leukemia

  2014cites this paper
• Synthetic and natural products as poisons of human topoisomerase II

  2013cites this paper
• A complex MLL rearrangement identified five years after initial MDS diagnosis results in out-of-frame fusions without progression to acute leukemia.

  2011cites this paper
• f Secondary Acute Promyelocytic Leukemia

  2011cites this paper
• Mediterranean Journal of Hematology and Infectious Diseases Molecular Pathogenesis of Secondary Acute

  2011cites this paper
• Covert preleukemia driven by MLL gene fusion

  2009influential citation
• Cytogenetic and Molecular Pathology of Pediatric Cancer

  2009cites this paper
• A safer regimen for high‐risk neuroblastoma

  2009cites this paper
• The Children's Hospital of Philadelphia Research Institute Impact Factor Report, FY2008

  2008cites this paper